Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sweeney

Showing results (701-710 of 762) with videos related to

Pageof 77
Sort By:
Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
JAMA Network Open|July 22, 2021
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line TherapyEdoardo Francini, Francesco Montagnani, Pier Vitale Nuzzo, et al.
Pain|August 27, 2021
Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic painPaulina Nunez-Badinez, Bianca De Leo, Alexis Laux-Biehlmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With RadiationWanling Xie, Meredith M Regan, Marc Buyse, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Journal of the National Cancer Institute|June 9, 2024
RET overexpression leads to increased brain metastatic competency in luminal breast cancerPetra Jagust, Aoibhin M Powell, Mihaela Ola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Cancer|April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypesAdam B Weiner, Yang Liu, Alex Hakansson, et al.
Pageof 77

Showing results (701-710 of 762) with videos related to

Sort By:
Pageof 77
Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.
JAMA Network Open|July 22, 2021
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line TherapyEdoardo Francini, Francesco Montagnani, Pier Vitale Nuzzo, et al.
Pain|August 27, 2021
Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic painPaulina Nunez-Badinez, Bianca De Leo, Alexis Laux-Biehlmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With RadiationWanling Xie, Meredith M Regan, Marc Buyse, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Journal of the National Cancer Institute|June 9, 2024
RET overexpression leads to increased brain metastatic competency in luminal breast cancerPetra Jagust, Aoibhin M Powell, Mihaela Ola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate CancerEmma H Allott, Ericka M Ebot, Konrad H Stopsack, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
Cancer|April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypesAdam B Weiner, Yang Liu, Alex Hakansson, et al.
Pageof 77